How Can We Solve the Enigma of Influenza Vaccine-Induced Protection?
Open Access
- 21 November 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 211 (10) , 1517-1518
Abstract
(See the major article by Ohmit et al on pages 1519–28.)Keywords
This publication has 11 references indexed in Scilit:
- Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza VaccinationThe Journal of Infectious Diseases, 2014
- Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 SeasonsClinical Infectious Diseases, 2014
- Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 20142014
- Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on EstimatesClinical Infectious Diseases, 2013
- The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trialsEurosurveillance, 2013
- The test-negative design for estimating influenza vaccine effectivenessVaccine, 2013
- Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case–control study, 2012/13Eurosurveillance, 2013
- Influenza Vaccine Effectiveness in the Community and the HouseholdClinical Infectious Diseases, 2013
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITALThe Lancet, 1979